Novavax Competitors and Similar CompaniesClear all
Novavax's competitors and similar companies include Adaptimmune.
 Novavax Novavax is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. |  Adaptimmune Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. | |
Founding Date | Founding Date 1987 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Gaithersburg, US HQ Jevany, CZ Uppsala, SE Rockville, US | Locations Philadelphia, US HQ Milton, GB Milton, GB Stevenage, GB |
Employees | Employees 16845% decrease | Employees 4007% decrease |
Valuation ($) | Valuation ($) 1.6 b | Valuation ($) 188.5 m |
Financial | ||
Revenue (est.) | Revenue (est.) $1.1b (FY, 2025) | Revenue (est.) $178m (FY, 2024) |
Cost of goods | Cost of goods $73m (FY, 2025) | Cost of goods $70k (FY, 2024) |
Gross profit | Gross profit $1.1b (FY, 2025) | Gross profit $178m (FY, 2024) |
Net income | Net income $440.3m (FY, 2025) | Net income ($70.8m) (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Adaptimmune
HQ
Philadelphia, US
Employees
400↓ 7% decrease
Adaptimmune Limited develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases.
View company